VAM
ENZY

Visium Asset Management’s Enzymotec Ltd ENZY Stock Holding History

Visium Asset Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,200,000
Closed -$19.9M – 566
2016
Q1 		$19.9M Hold
2,200,000
– – 0.34% 70
2015
Q4 		$21.6M Hold
2,200,000
– – 0.32% 62
2015
Q3 		$19.9M Hold
2,200,000
– – 0.27% 75
2015
Q2 		$18.4M Buy
2,200,000
+40,000
+2% +$367K 0.26% 73
2015
Q1 		$15.6M Buy
2,160,000
+35,000
+2% +$248K 0.23% 94
2014
Q4 		$16M Hold
2,125,000
– – 0.23% 82
2014
Q3 		$14.2M Buy
2,125,000
+25,000
+1% +$270K 0.21% 105
2014
Q2 		$28.5M Buy
2,100,000
+960,000
+84% +$16.1M 0.44% 38
2014
Q1 		$25.1M Buy
1,140,000
+450,000
+65% +$11.9M 0.41% 50
2013
Q4 		$18.6M Buy
+690,000
New +$16.4M 0.37% 58

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Visium Asset Management's ENZY Position: Q2 2016 in Review

Visium Asset Management sold out of Enzymotec Ltd (ENZY) in Q2 2016, closing a stake of 2,200,000 shares — an estimated $19.9M sold.

Visium Asset Management first reported a position in ENZY in Q4 2013 and held it in 10 quarters. The position peaked at $28.5M in Q2 2014. 34 funds tracked by Wall St. Rank hold ENZY as of Q2 2016.

  • Visium Asset Management reported no remaining Enzymotec Ltd position as of Q2 2016 after selling out during the quarter.
  • Visium Asset Management sold 2,200,000 Enzymotec Ltd shares in Q2 2016, an estimated $19.9M.
  • Visium Asset Management first reported a position in Enzymotec Ltd in Q4 2013 and held it in 10 quarters.
  • Visium Asset Management's Enzymotec Ltd position peaked at $28.5M in Q2 2014.
  • 34 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.